Since the link between MATN1‐AS1/E2F2 and EMT, we are speculating on the underlying effect of the MATN1‐AS1/E2F2 axis in sunitinib (a classic TKI in RCC treatment) resistance. This evidence concerns the gene E2F2 and renal cell carcinoma.